- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 27.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 27.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 27.06M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$979.32K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $8.15M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.11M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.17M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.18M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.85M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.22M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.92M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.47M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $9.27M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.81M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $13.57M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $447.21K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $337.99K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $450.91K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $318.74K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.37M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.48M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.42M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.57M |
| Capex | Q1 2026 · Mar 31, 2025 | $869.58K |